| First Author | De Jesus A | Year | 2022 |
| Journal | Mol Cell | Volume | 82 |
| Issue | 7 | Pages | 1261-1277.e9 |
| PubMed ID | 35305311 | Mgi Jnum | J:339135 |
| Mgi Id | MGI:7286113 | Doi | 10.1016/j.molcel.2022.02.028 |
| Citation | De Jesus A, et al. (2022) Hexokinase 1 cellular localization regulates the metabolic fate of glucose. Mol Cell 82(7):1261-1277.e9 |
| abstractText | The product of hexokinase (HK) enzymes, glucose-6-phosphate, can be metabolized through glycolysis or directed to alternative metabolic routes, such as the pentose phosphate pathway (PPP) to generate anabolic intermediates. HK1 contains an N-terminal mitochondrial binding domain (MBD), but its physiologic significance remains unclear. To elucidate the effect of HK1 mitochondrial dissociation on cellular metabolism, we generated mice lacking the HK1 MBD (DeltaE1HK1). These mice produced a hyper-inflammatory response when challenged with lipopolysaccharide. Additionally, there was decreased glucose flux below the level of GAPDH and increased upstream flux through the PPP. The glycolytic block below GAPDH is mediated by the binding of cytosolic HK1 with S100A8/A9, resulting in GAPDH nitrosylation through iNOS. Additionally, human and mouse macrophages from conditions of low-grade inflammation, such as aging and diabetes, displayed increased cytosolic HK1 and reduced GAPDH activity. Our data indicate that HK1 mitochondrial binding alters glucose metabolism through regulation of GAPDH. |
